SINOPHARM(01099): The net profit attributable to shareholders of China National Medicines Corporation(600511.SH) in the first quarter was 474 million yuan, a year-on-year increase of 3.32%.

20:15 22/04/2026

China National Pharmaceutical Group Corporation (01099) released the performance of China National Pharmaceutical Group (600511.SH) for the first quarter of 2026. The company achieved operating income of 13.555 billion yuan, a year-on-year increase of 6.63%; net profit attributable to shareholders was 747 million yuan, a year-on-year increase of 3.32%; basic earnings per share were 0.6286 yuan.

SINOPHARM (01099) releases China National Medicines Corporation (600511.SH) performance data for the first quarter of 2026. The company achieved operating income of 13.555 billion yuan, a year-on-year increase of 6.63%; net profit attributable to the parent company was 474 million yuan, a year-on-year increase of 3.32%; basic earnings per share were 0.6286 yuan.

DL Holdings GP (01709) spent HK$620,700 to repurchase 600,000 shares on April 22.

CSTONE PHARMA-B (02616) issued 118 million new shares in accordance with the placing agreement.

US Stock Market Move | Q1 performance exceeds expectations, GE Vernova (GEV.US) opened with a big jump of over 12%.

DL Holdings GP (01709) spent HK$620,700 to repurchase 600,000 shares on April 22.

CSTONE PHARMA-B (02616) issued 118 million new shares in accordance with the placing agreement.

US Stock Market Move | Q1 performance exceeds expectations, GE Vernova (GEV.US) opened with a big jump of over 12%.